Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
author: Diederik F M Hentenaar, Yvonne C M De Waal, Hans Strooker, Henny J A Meijer, Arie-Jan Van Winkelhoff, Gerry M Raghoebar | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
Outcome variable
Crude modela
β (95% CI)
p value
Adjusted modelb
β (95% CI)
p-value
% Sites BoP
% Sites SoP
Mean PPD
16.2 (−7.9 to 40.3)
0.0 (−10.9 to 10.9)
0.6 (−0.6 to 1.8)
0.743
1.000
0.205
7.9 (−16.4 to 32.3)
0.7 (−10.1 to 11.4)
0.2 (−1.0 to 1.3)
0.821
0.882
0.470
Serial posts:
-
Implant decontamination with phosphoric acid
-
Background : Implant decontamination with phosphoric acid
-
Methods : Implant decontamination with phosphoric acid
-
Interventions : Implant decontamination with phosphoric acid
-
Outcomes : Implant decontamination with phosphoric acid
-
Randomization : Implant decontamination with phosphoric acid
-
Statistical analysis : Implant decontamination with phosphoric acid
-
Results : Implant decontamination with phosphoric acid (1)
-
Results : Implant decontamination with phosphoric acid (2)
-
Discussion : Implant decontamination with phosphoric acid (1)
-
Discussion : Implant decontamination with phosphoric acid (2)
-
Discussion : Implant decontamination with phosphoric acid (3)
-
References : Implant decontamination with phosphoric acid
-
Table 1 Characteristics of included patients/implants
-
Table 2 Log-transformed mean bacterial anaerobic counts
-
Table 3 Log-transformed mean bacterial anaerobic counts
-
Table 4 Descriptive statistics of clinical parameters
-
Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
-
Figure 1. Flow diagram
Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
| Outcome variable | Crude modela β (95% CI) |
p value | Adjusted modelb β (95% CI) |
p-value |
|---|---|---|---|---|
| % Sites BoP % Sites SoP Mean PPD |
16.2 (−7.9 to 40.3) 0.0 (−10.9 to 10.9) 0.6 (−0.6 to 1.8) |
0.743 1.000 0.205 |
7.9 (−16.4 to 32.3) 0.7 (−10.1 to 11.4) 0.2 (−1.0 to 1.3) |
0.821 0.882 0.470 |
- Implant decontamination with phosphoric acid
- Background : Implant decontamination with phosphoric acid
- Methods : Implant decontamination with phosphoric acid
- Interventions : Implant decontamination with phosphoric acid
- Outcomes : Implant decontamination with phosphoric acid
- Randomization : Implant decontamination with phosphoric acid
- Statistical analysis : Implant decontamination with phosphoric acid
- Results : Implant decontamination with phosphoric acid (1)
- Results : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (1)
- Discussion : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (3)
- References : Implant decontamination with phosphoric acid
- Table 1 Characteristics of included patients/implants
- Table 2 Log-transformed mean bacterial anaerobic counts
- Table 3 Log-transformed mean bacterial anaerobic counts
- Table 4 Descriptive statistics of clinical parameters
- Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
- Figure 1. Flow diagram